Analysis of the pandemic’s COVID-19 impact on the oncological situation (based on literature review)
DOI:
https://doi.org/10.32782/2077-6594/2023.2/03Keywords:
malignant neoplasms, COVID-19, screening, mortality, lung cancer, organization of medical careAbstract
Objective. The aim of this study was to investigate and analyze domestic and international scientific publications regarding the peculiarities of providing medical care to cancer patients in the context of COVID-19. Materials and methods. Scientific databases (Google Scholar, PubMed, Scopus, Web of Science), websites of scientific journals, and repositories of higher education institutions were used for literature analysis. Results. A total of 23 scientific papers published from 2020 to 2023 were analyzed, revealing that the primary focus of publications was the impact of COVID-19 on the provision of comprehensive medical care for malignancies, including lung cancer. Conclusions. Based on the analysis conducted, it can be concluded that the impact of COVID-19 on oncological diseases is inevitable. However, through well-planned efforts by clinicians and proper public awareness of the risk of not seeking medical assistance when exhibiting symptoms suggestive of cancer, this impact can be minimized.
References
Klaassen Z, Wallis CJD. Assessing patient risk from cancer and COVID-19: Managing patient distress. Urol Oncol. 2021May;39(5):243–246.
Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, Merkx MAW, Lemmens VEPP, Nagtegaal ID, Siesling S. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020 Jun;21(6):750–751.
Douglas A. Ritzwoller, Debra P. Greenlee, Robert T. Neslund-Dudas, Christine Rendle, Katharine A. Honda, Stacey A. Schottinger, Joanne E. Udaltsova, Natalia Vachani, Anil Kobrin, Sarah Li, Christopher I. Haas, Jennifer S. et al. Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute’s PROSPR Consortium Corley. Gastroenterology. 2020;160(4):999–1002.
Bouanani N., Bendari M., Naim A., Ahnach, M., Darouich, S., Ismaili, N., & Doghmi, K. Managing Cancer Center During the SARS-COVID-19 Pandemic: Moroccan Experience. Asian Pacific Journal of Cancer Care. 5(S1):219–223.
CMS Releases Recommendations on Adult Elective Surgeries, Non-Essential Medical, Surgical, and Dental Procedures During COVID-19 Response | CMS. Home – Centers for Medicare & Medicaid Services | CMS. URL: https://www.cms.gov/newsroom/press-releases/cms-releases-recommendations-adult-elective-surgeries-non-essential-med.
Roadevin C, Hill HHow can we decide a fair allocation of healthcare resources during a pandemic? Journal of Medical Ethics. 2021;47:e84.
Luker G. D., Boettcher A. N. Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now. Radiology: Imaging Cancer. 2021;3(1):e210003.
Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung SH, Ambrosy AP, Sidney S, Go AS. The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. N Engl J Med. 2020Aug13;383(7):691–693.
A and B Recommendations | United States Preventive Services Taskforce. Home page | United States Preventive Services Taskforce. URL: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-and-b-recommendations.
Maringe, Camille et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. The Lancet Oncology. 2020;21(8):1023–1034.
Schrag D, Hershman DL, Basch E. Oncology Practice During the COVID-19 Pandemic. JAMA. 2020 May 26; 323 (20): 2005–2006.
Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021Mar;9(3):e002266.
The Lancet Oncology. Safeguarding cancer care in a post-COVID-19 world. Lancet Oncol. 2020 May; 21 (5): 603.
Del Vecchio Blanco G, Calabrese E, Biancone L, Monteleone G, Paoluzi OA. The impact of COVID-19 pandemic in the colorectal cancer prevention. Int J Colorectal Dis. 2020 Oct; 35(10):1951–1954.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020Mar;21(3):335–337.
Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020 May 12;323 (18): 1775–1776.
Partha Basu, Samar Alhomoud, Katayoun Taghavi, Andre L. Carvalho, Eric Lucas, and Iacopo Baussano. Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation. JCO Global Oncology. 2021;7:416–424.
Burki, Talha Khan. Cancer guidelines during the COVID-19 pandemic. The Lancet Oncology. 21,5:629–630.
Al-Quteimat OM, Amer AM. The Impact of the COVID-19 Pandemic on Cancer Patients. Am J Clin Oncol. 2020Jun;43(6):452–455.
COVID-19 and Cancer. European Society for Medical Oncology. URL: https://www.esmo.org/covid-19-and-cancer.
R. Simcock et al. COVID-19: Global radiation oncology’s targeted response for pandemic preparedness. Clinical and Translational Radiation Oncology. 2020;22:55–68.
Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020Apr;21(4):181.
Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy. 2020;12(5):269–273.
